Bacterial Properties With LoFric® Catheters During Clean Intermittent Catheterization

Withdrawn before enrolling · Phase 1/Phase 2

Conditions studied: Neurogenic Bladder, Urinary Retention

In brief

The primary objective of our study is to examine characteristics of bacteria that are discovered in urine from pediatric patients that utilize either LoFric® or non-LoFric® catheters for self intermittent catheterization. The investigators hypothesize that the hydrophilic nature of the LoFric® catheter will alter the microbial environment and reduce clinically significant urinary tract infections in patients with neurogenic bladder compared to a similar population using standard catheters. Secondary outcomes will be comparing the incidence of clinical urinary tract infections between patients that use standard catheters and those that use LoFric catheters. Lastly, patient satisfaction using LoFric catheters compared to standard catheters will be assessed.

Key facts

Study ID

NCT01305681

Run by

Nationwide Children's Hospital

People needed

0

Starts

2011-05-06

Expected to finish

2012-02-21

Last updated by the study team

2019-08-07

Who can join

Age: any, up to 35. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who perform clean intermittent catheterization on a regular basis

You may not qualify if…

• Patients on daily continuous antibiotic therapy

Where it is running

• Nationwide Children's Hospital — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.